SLC1A2 and Alzheimer disease: Another study suggested that CEF could improve the cognitive impairments of APP/PS1 mice in the early stage of Alzheimer’s disease by upregulating GLT-1 and Nglutamine transporter 1 (SN1) expression and increasing the activity of the GS enzyme (Fan et al., 2018).